Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Medx Health Corp V.MDX

Alternate Symbol(s):  MDXHF

MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and,... see more

TSXV:MDX - Post Discussion

Medx Health Corp > Investor Intel update with Mike
View:
Post by Dunworkin2 on Jan 26, 2022 7:12pm

Investor Intel update with Mike

Aiming to have 158 scopes in play by end of Q1. He also vaguely touched on Brazil. No word on Mexico.

https://youtu.be/4-ncyM6DgU4
Comment by Insightful1 on Jan 26, 2022 11:10pm
If you do some back of the napkin numbers Q1 would potentially see this kind of revenue; 158 scopes @$5,000                                                       = $790,000 in hardware revenue 158 scopes x 5 scans a day x$15 per scan x 60 days    ...more  
Comment by Dunworkin2 on Jan 27, 2022 7:37am
Well since Mdx did $94,000 in sales for Q3, even being a bit more cautious with your estimate and say the installs are late getting out so they only do $200,000 in recurring revenue, we would still be at $1M in sales for Q1 which would be phenomenal. Let's hope Q4 starts off a nice trend up and Q1 (reported by May 31) takes off.  Any luck finding out Beacon's net share position?
Comment by Insightful1 on Jan 27, 2022 9:43am
Beacon is a brokerage firm and as such merely acts as an agent. They write research coverage, amd get paid a fee to introduce MedX to their investors in the case of a financing. Beacon does not invest in MedX or any other companies they provide research to.  I suspect as MedX starts to show revenue they will get more fully engaged and go back to their investors until then I suspect they ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities